Price $4.90 |
Market Cap
203.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
3.8
|
P/B
0.33
|
P/S
0.29
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
4.4
|
Op. Cash Flow
118.5K
|
FCF
1.2
|
|
Op. Margin
19.00%
|
Net Margin
4.20%
|
ROE
4.80%
|
ROI
8.10%
|
|
ROA
1.80%
|
EPS Growth
-
|
Current Ratio
2.6
|
Debt/Equity
129.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $15.85 | - | - | 3.74B | Strong Buy |
| Vaxart Inc (VXRT) | $2.67 | - | - | 21.9M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $3.51 | - | - | 32M | Strong Buy |
| Procyon Corp (PCYN) | $0.23 | - | - | 2M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.60 | - | - | 96.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
